Herpes Zoster Pipeline Assessment (2023) Covering Clinical Trials, Emerging Therapies, FDA, EMA, and PMDA Approvals | Curevo Vaccine, Dynavax, Enzolytics, EuBiologics, HilleVax, Merck, NanoViricides, Nobelpharma, Pfizer, Vaccitech, Vapogenix, XBiotech

Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, several major pharma and biotech companies are working on developing novel therapies for the Herpes Zoster treatment based on different Routes of Administration (ROA), Mechanism of Action (MOA), and molecule types. Several of the therapies are in the advanced stages of clinical development and are expected to launch in the coming years.

The Herpes Zoster therapeutics market is anticipated to evolve immensely in the coming years owing to the rising prevalent population of Herpes Zoster patients and the launch of emerging therapies. Companies across the globe are working toward the development of new treatment therapies for Herpes Zoster, Future goals include developing new vaccines for specific groups, such as immunocompromised individuals, and developing an evidence base on which type of immunocompromised individuals can be safely and effectively vaccinated with a live-attenuated vaccine.

"Herpes Zoster Pipeline Insight, 2023" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Herpes Zoster Therapeutics Market.

The report provides a detailed description of the Herpes Zoster drugs, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any). The report also covers commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed stage. Additionally, it presents the ongoing developments in the therapeutics segment, including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Get a Detailed Overview of the Herpes Zoster Clinical Trial Activities and Regulatory Developments in the domain:
https://www.delveinsight.com/report-store/herpes-zoster-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Herpes Zoster Pipeline Analysis
The report provides insights into:
• The report provides detailed insights into the key companies that are developing Herpes Zoster therapies.
• The report also evaluates different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Herpes Zoster treatment.
• It analyzes the key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• It navigates the emerging Herpes Zoster drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement in the Herpes Zoster treatment market.

Learn More about the Clinical and Commercial Development Activities in the Herpes Zoster Therapeutics Domain:
https://www.delveinsight.com/report-store/herpes-zoster-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Herpes Zoster Therapeutics Landscape
Several major pharma and biotech giants are developing therapies for Herpes Zoster. Currently, Curevo Inc. is leading the therapeutics market with its Herpes Zoster drug candidates in the most advanced stage of clinical development.

The Leading Companies in the Herpes Zoster Therapeutics Market Include:
AIM Vaccine, Akshaya Bio, CPL Biologicals, Curevo Vaccine, Dynavax Technologies, Enzolytics, EuBiologics, EyeGene, Gene One Life Science, GlaxoSmithKline, HilleVax, Inc., Merck Sharp & Dohme Corp, NAL Pharma, NanoViricides, Nobelpharma, Pfizer, Shulov Innovative Science, Shulov Institute for Science LTD., Turn therapeutics, Vaccitech, Vapogenix, XBiotech, and others.

Herpes Zoster Emerging and Marketed Drugs Covered in the Report Include:
• CRV-101: Curevo Inc.
• EG-HZ: EyeGene
• NPC-06:Nobelpharma
• Shingrix: GlaxoSmithKline
• VARIVAX: Merck Sharp & Dohme Corp
• ZEP-3: Shulov Institute for Science LTD.
And Many More

Get an in-depth Assessment of the Emerging Therapies and Herpes Zoster Companies Actively Working in the Market:
https://www.delveinsight.com/sample-request/herpes-zoster-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

The Report Covers the Emerging Herpes Zoster Therapies Under Different Phases of Clinical Development Like -
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates

Route of Administration
Herpes Zoster pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs such as
• Intra-articular
• Intraocular
• Intrathecal
• Intravenous
• Ophthalmic
• Oral
• Parenteral
• Subcutaneous
• Topical
• Transdermal

Molecule Type
Products have been categorized under various Molecule types such as
• Oligonucleotide
• Peptide
• Small molecule

Request for Sample PDF to Understand More About the Herpes Zoster Treatment Outlook and Future Perspectives:
https://www.delveinsight.com/sample-request/herpes-zoster-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Herpes Zoster Current Treatment Patterns
4. Herpes Zoster - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Herpes Zoster Late-Stage Products (Phase-III)
7. Herpes Zoster Mid-Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Herpes Zoster Discontinued Products
13. Herpes Zoster Product Profiles
14. Herpes Zoster Companies
15. Herpes Zoster Drugs
16. Dormant and Discontinued Products
17. Herpes Zoster Unmet Needs
18. Herpes Zoster Future Perspectives
19. Herpes Zoster Analyst Review
20. Appendix
21. Report Methodology

Get Detailed Insights About the Reports Offerings:
https://www.delveinsight.com/sample-request/herpes-zoster-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

-------------------------------------------- xx --------------------------------------------
Other Trending Healthcare Reports by DelveInsight
Artificial Disc Market
https://www.delveinsight.com/report-store/artificial-disc-market

Corneal Endothelial Dystrophy Market
https://www.delveinsight.com/report-store/corneal-endothelial-dystrophy-market

Bone Neoplasms Market
https://www.delveinsight.com/report-store/bone-neoplasms-market

Duchenne Muscular Dystrophy Market
https://www.delveinsight.com/report-store/duchenne-muscular-dystrophy-market

Secondary Hyperparathyroidism Market
https://www.delveinsight.com/report-store/secondary-hyperparathyroidism-market

Fetal Monitoring Devices Market
https://www.delveinsight.com/report-store/fetal-monitoring-devices-market

Relapsing Multiple Sclerosis (RMS) Market
https://www.delveinsight.com/report-store/relapsing-multiple-sclerosis-rms-market

Interspinous Spacers Market
https://www.delveinsight.com/report-store/interspinous-spacers-market

Cerebral Palsy Market
https://www.delveinsight.com/report-store/cerebral-palsy-market

Glioblastoma Market
https://www.delveinsight.com/report-store/glioblastoma-market

Breast Pumps Market
https://www.delveinsight.com/report-store/breast-pumps-market

Diabetic Peripheral Neuropathy Market
https://www.delveinsight.com/report-store/diabetic-peripheral-neuropathy-market

Throat Cancer Market
https://www.delveinsight.com/report-store/throat-cancer-market

Osteoporosis Market
https://www.delveinsight.com/report-store/osteoporosis-market

Implantable Cardioverter Defibrillators (ICDs) Market
https://www.delveinsight.com/report-store/implantable-cardioverter-defibrillators-icds-market

Open-Angle Glaucoma Market
https://www.delveinsight.com/report-store/open-angle-glaucoma-market

Atopic Dermatitis Market
https://www.delveinsight.com/report-store/atopic-dermatitis-market

Prurigo Nodularis Market
https://www.delveinsight.com/report-store/prurigo-nodularis-market

Erectile Dysfunction Market
https://www.delveinsight.com/report-store/erectile-dysfunction-market

Varicose Ulcer Market
https://www.delveinsight.com/report-store/varicose-ulcer-market

Trastuzumab Biosimilars
https://www.delveinsight.com/report-store/trastuzumab-biosimilars-insight

Poly (ADP-Ribose) Polymerase 1 (PARP) Inhibitor Pipeline Insight
https://www.delveinsight.com/report-store/poly-adp-ribose-polymerase-1-parp-inhibitor-pipeline-insight

Stereotactic Surgery Devices Market
https://www.delveinsight.com/report-store/stereotactic-surgery-devices-market

Acute lymphocytic leukemia (ALL) Market
https://www.delveinsight.com/report-store/acute-lymphocytic-leukemia-all-market

Eczema Market
https://www.delveinsight.com/report-store/eczema-market

Traumatic Brain Injury Market
https://www.delveinsight.com/report-store/traumatic-brain-injury-market

Hemostats Market
https://www.delveinsight.com/report-store/hemostats-market

Gastroesophageal Reflux Disease (GERD) Market
https://www.delveinsight.com/report-store/gastroesophageal-reflux-disease-gerd-market

Peripheral Vascular Devices Market
https://www.delveinsight.com/report-store/peripheral-vascular-devices-market

Obesity Market
https://www.delveinsight.com/report-store/weight-loss-weight-management-obesity-market

Urinary Incontinence Market
https://www.delveinsight.com/report-store/urinary-incontinence-market

Hemostasis Market
https://www.delveinsight.com/report-store/hemostasis-market

Intracardiac Echocardiography Devices Market
https://www.delveinsight.com/report-store/intracardiac-echocardiography-devices-market

Contact Info:
Shruti Thakur
Manager - Marketing & International Branding
Email: info@delveinsight.com

428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

This release was published on openPR.